The regulation of YY1 in tumorigenesis and its targeting potential in cancer therapy

Molecular and Cellular Pharmacology

Volumn 1, Issue 3, 2009, Pages 157-176

  Sui, Guangchao ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer therapy; Epigenetic regulation; Tumorigenesis; YY1

Indexed keywords

DNA; TRANSCRIPTION FACTOR YY1;

ACETYLATION; APOPTOSIS; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; DNA DAMAGE; EPIGENETICS; GENE EXPRESSION; GENE TARGETING; METHYLATION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REVIEW; SUMOYLATION; UBIQUITINATION;

EID: 77953419714     PISSN: None     EISSN: 19381247     Source Type: Journal    
DOI: 10.4255/mcpharmacol.09.20     Document Type: Review

References (192)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Shi Y, Lee JS, Galvin KM. Everything you have ever wanted to know about Yin Yang 1...... Biochim Biophys Acta 1997;1332:F49-66.
3. Thomas MJ, Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 1999;236:197-208.
4. Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 2006;25:1125-42.
5. Wang CC, Chen JJ, Yang PC. Multifunctional transcription factor YY1: a therapeutic target in human cancer? Expert Opin Ther Targets 2006;10:253-66.
6. Castellano G, Torrisi E, Ligresti G, et al. The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle 2009;8:1367-72.
7. Shi Y, Seto E, Chang LS, Shenk T. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 1991;67:377-88.
8. Seto E, Shi Y, Shenk T. YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature 1991;354:241-5.
9. Park K, Atchison ML. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3′ enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci USA 1991;88:9804-8.
10. Hariharan N, Kelley DE, Perry RP. Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. Proc Natl Acad Sci U S A 1991;88:9799-803.
11. Flanagan JR, Becker KG, Ennist DL, et al. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol Cell Biol 1992;12:38-44.
12. Safrany G, Perry RP. Characterization of the mouse gene that encodes the delta/YY1/NF-E1/UCRBP transcription factor. Proc Natl Acad Sci USA 1993;90:5559-63.
13. Chen KS, Paladugu A, Aldaz CM, Gould MN, Cloning and chromosomal localization of the rat Stat5 and Yy1 genes. Cytogenet Cell Genet 1996;74:277-80.
14. Bernard M, Voisin P. Photoreceptor-specific expression, light-dependent localization, and transcriptional targets of the zinc-finger protein Yin Yang 1 in the chicken retina. J Neurochem 2008;105:595-604.
15. Song HD, Sun XJ, Deng M, et al. Hematopoietic gene expression profile in zebrafish kidney marrow. Proc Natl Acad Sci USA 2004;101:16240-5.
16. Pisaneschi G, Ceccotti S, Falchetti ML, Fiumicino S, Carnevali F, Beccari E. Characterization of FIII/YY1, a Xenopus laevis conserved zinc-finger protein binding to the first exon of L1 and L14 ribosomal protein genes. Biochem Biophys Res Commun 1994;205:1236-42.
17. Brown JL, Fritsch C, Mueller J, Kassis JA. The Drosophila pho-like gene encodes a YY1-related DNA binding protein that is redundant with pleiohomeotic in homeotic gene silencing. Development 2003;130:285-94.
18. Brown JL, Mucci D, Whiteley M, Dirksen ML, Kassis JA. The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. Mol Cell 1998;1:1057-64.
19. Nguyen N, Zhang X, Olashaw N, Seto E. Molecular cloning and functional characterization of the transcription factor YY2. J Biol Chem 2004;15:15.
20. Kim JD, Faulk C, Kim J. Retroposition and evolution of the DNA-binding motifs of YY1, YY2 and REX1. Nucleic Acids Res 2007;35:3442-52.
21. Luo C, Lu X, Stubbs L, Kim J. Rapid evolution of a recently retroposed transcription factor YY2 in mammalian genomes. Genomics 2006;87:348-55.
22. Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y. Targeted disruption transcription factor results in peri-implantation lethality. Mol Cell Biol 1999;19:7237-44.
23. Donohoe ME, Zhang LF, Xu N, Shi Y, Lee JT. Identification of a ctcf cofactor, yy1, for the x chromosome binary switch. Mol Cell 2007;25:43-56.
24. Liu H, Schmidt-Suppian M, Shi Y, et al. Yin Yang 1 is a critical regulator of B-cell development. Genes Dev 2007;21:1179-89.
25. Kim J, Kim JD. In vivo YY1 knockdown effects on genomic imprinting. Hum Mol Genet 2008;17:391-401.
26. He Y, Dupree J, Wang J, et al. The transcription factor yin yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 2007;55:217-30.
27. He Y, Casaccia-Bonnefil P. The Yin and Yang of YY1 in the nervous system. J Neurochem 2008;106(4):1493-502.
28. Affar el B, Gay F, Shi Y, et al. Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression. Mol Cell Biol 2006;26:3565-81.
29. Yant SR, Zhu W, Millinoff D, Slightom JL, Goodman M, Gumucio DL. High affinity YY1 binding motifs: identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human beta globin cluster. Nucleic Acids Res 1995;23:4353-62.
30. Kim J, Kim J. YY1's longer DNA-binding motifs. Genomics 2009;93:152-8.
31. Hyde-DeRuyscher RP, Jennings E, Shenk T. DNA binding sites for the transcriptional activator/repressor YY1. Nucleic Acids Res 1995;23:4457-65.
32. Palko L, Bass HW, Beyrouthy MJ, Hurt MM. The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase. J Cell Sci 2004;117(Pt 3):465-76.
33. Riggs KJ, Saleque S, Wong KK, et al. Yin-yang 1 activates the c-myc promoter. Mol Cell Biol 1993;13:7487-95.
34. Kadeppagari RK, Sankar N, Thimmapaya B. Adenovirus transforming protein E1A induces c-Myc in quiescent cells by a novel mechanism. J Virol 2009;83:4810-22.
35. Zhou Q, Gedrich RW, Engel DA. Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB. J Virol 1995;69:4323-30.
36. Zhou Q, Engel DA. Adenovirus E1A243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter. J Virol 1995;69:7402-9.
37. Natesan S, Gilman M. YY1 facilitates the association of serum response factor with the c-fos serum response element. Mol Cell Biol 1995;15:5975-82.
38. Begon DY, Delacroix L, Vernimmen D, Jackers P, Winkler R. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. J Biol Chem 2005;280:24428-34.
39. Allouche A, Nolens G, Tancredi A, et al. The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. Breast Cancer Res 2008;10:R9.
40. Harari D, Yarden Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 2000;19(53):6102-14.
41. Seshadri R, Matthews C, Dobrovic A, Horsfall DJ. The significance of oncogene amplification in primary breast cancer. Int J Cancer 1989;43:270-2.
42. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 2007;67(8):3496-9.
43. Baumeister P, Luo S, Skarnes WC, et al. Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol Cell Biol, 2005;25:4529-40.
44. Palmer MB, Majumder P, Cooper JC, Yoon H, Wade PA, Boss JM. Yin Yang 1 regulates the expression of Snail through a distal enhancer. Mol Cancer Res 2009;7:221-9.
45. Tan DP, Nonaka K, Nuckolls GH, et al. YY1 activates Msx2 gene independent of bone morphogenetic protein signaling. Nucleic Acids Res 2002;30:1213-23.
46. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007;450:736-40.
47. Sui G, Affar el B, Shi Y, et al. Yin Yang 1 is a negative regulator of p53. Cell 2004;117:859-72.
48. Gronroos E, Terentiev AA, Punga T, Ericsson J. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci USA 2004;101:12165-70.
49. Yakovleva T, Kolesnikova L, Vukojevic V, et al. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. Biochem Biophys Res Commun 2004;318:615-24.
50. Bain M, Sinclair J. Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death. Eur J Cell Biol 2005;84:543-53.
51. Furlong EE, Rein T, Martin F. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. Mol Cell Biol 1996;16:5933-45.
52. Wu S, Murai S, Kataoka K, Miyagishi M. Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1. Biochem Biophys Res Commun 2008;365:75-81.
53. Wang CC, Tsai MF, Dai TH, et al. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1. Cancer Res 2007;67:4816-26.
54. Delehouzee S, Yoshikawa T, Sawa C, et al. GABP, HCF-1 and YY1 are involved in Rb gene expression during myogenesis. Genes Cells 2005;10:717-31.
55. Santiago FS, Ishii H, Shafi S, et al. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly. Circ Res 2007;101:146-55.
56. Wang X, Feng Y, Xu L, et al. YY1 restrained cell senescence through repressing the transcription of p16. Biochim Biophys Acta 2008;1783:1876-83.
57. Wang H, Garzon R, Sun H, et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008;14:369-81.
58. Lee JS, Galvin KM, See RH, et al. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev 1995;9:1188-98.
59. Li M, Luo J, Brooks CL, Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 2002;277:50607-11.
60. Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W. Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 2004;101:2259-64.
61. Yang WM, Inouye C, Zeng Y, Bearss D, Seto E. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci USA 1996;93:12845-50.
62. Luke MP, Sui G, Liu H, Shi Y. Yin Yang 1 physically interacts with HOXA11 and represses HOXA11-dependent transcription. J Biol Chem 2006;281:33226-32
63. Ren G, Zhang G, Dong Z, et al. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers. Int J Biochem Cell Biol 2009;41:1094-101.
64. Yao YL, Yang WM, Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol 2001;21:5979-91.
65. Rezai-Zadeh N, Zhang X, Namour F, et al. Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes Dev 2003;17:1019-29.
66. Wang L, Brown JL, Cao R, Zhang Y, Kassis JA, Jones RS. Hierarchical recruitment of polycomb group silencing complexes. Mol Cell, 2004;14:637-46.
67. Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 2004;18:2627-38.
68. Wilkinson FH, Park K, Atchison ML. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc Natl Acad Sci USA 2006;103:19296-301.
69. Rylski M, Amborska R, Zybura K, et al. Yin Yang 1 is a critical repressor of matrix metalloproteinase-9 expression in brain neurons. J Biol Chem 2008;283:35140-53.
70. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 2004;18:2046-59.
71. Gill G. Something about SUMO inhibits transcription. Curr Opin Genet Dev 2005;15:536-41.
72. Deng Z, Wan M, Sui G. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger. Mol Cell Biol 2007;27:3780-92.
73. Hiromura M, Choi CH, Sabourin NA, Jones H, Bachvarov D, Usheva A. YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation). J Biol Chem 2003;278:14046-52.
74. Jackson SP, Tjian R. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell 1988;55:125-33.
75. Griesenbeck J, Ziegler M, Tomilin N, Schweiger M, Oei SL. Stimulation of the catalytic activity of poly(ADP-ribosyl) transferase by transcription factor Yin Yang 1. FEBS Lett 1999;443:20-4.
76. Oei SL, Shi Y. Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage. Biochem Biophys Res Commun 2001;285:27-31.
77. Eliassen KA, Baldwin A, Sikorski EM, Hurt MM. Role for a YY1-binding element in replication-dependent mouse histone gene expression. Mol Cell Biol 1998;18:7106-18.
78. Last TJ, van Wijnen AJ, Birnbaum MJ, Stein GS, Stein JL. Multiple interactions of the transcription factor YY1 with human histone H4 gene regulatory elements. J Cell Biochem 1999;72:507-16.
79. Inouye CJ, Seto E. Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J Biol Chem 1994;269:6506-10.
80. Weng JJ, Yung BY. Nucleophosmin/B23 regulates PCNA promoter through YY1. Biochem Biophys Res Commun 2005;335:826-31.
81. Srinivasan L, Atchison ML. YY1 DNA binding and PcG recruitment requires CtBP. Genes Dev 2004;18:2596-601.
82. Atchison L, Ghias A, Wilkinson F, Bonini N, Atchison ML. Transcription factor YY1 functions as a PcG protein in vivo. EMBO J 2003;22:1347-58.
83. Garcia E, Marcos-Gutierrez C, del Mar Lorente M, Moreno JC, Vidal M. RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1. EMBO J 1999;18:3404-18.
84. Schlisio S, Halperin T, Vidal M, Nevins JR. Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J 2002;21:5775-86.
85. Chen D, Zhang J, Li M, Rayburn ER, Wang H, Zhang R. RYBP stabilizes p53 by modulating MDM2. EMBO Rep 2009;10:166-72.
86. Huang NE, Lin CH, Lin YS, Yu WC. Modulation of YY1 activity by SAP30. Biochem Biophys Res Commun 2003;306:267-75.
87. Le May N, Mansuroglu Z, Leger P, et al. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 2008;4:e13.
88. Cai Y, Jin J, Yao T, et al. YY1 functions with INO80 to activate transcription. Nat Struct Mol Biol 2007;14:872-4.
89. Wu S, Shi Y, Mulligan P, et al. A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair. Nat Struct Mol Biol 2007;14:1165-72.
90. Gordon SJ, Saleque S, Birshtein BK. Yin Yang 1 is a lipopolysaccharide- inducible activator of the murine 3' Igh enhancer, hs3. J Immunol 2003;170:5549-57.
91. Petkova V, Romanowski MJ, Sulijoadikusumo I, et al. Interaction between YY1 and the retinoblastoma protein. Regulation of cell cycle progression in differentiated cells. J Biol Chem 2001;276:7932-6.
92. Shrivastava A, Yu J, Artandi S, Calame K. YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. Proc Natl Acad Sci USA 1996;93:10638-41.
93. Vernon EG, Gaston K. Myc and YY1 mediate activation of the Surf-1 promoter in response to serum growth factors. Biochim Biophys Acta 2000;1492:172-9.
94. Kang JH, Chang SY, Yeom DH, Kim SA, Um SJ, Hong KJ. Weakening of the repressive YY-1 site on the thrombospondin-1 promoter via c-Jun/YY-1 interaction. Exp Mol Med 2004;36:300-10.
95. Krippner-Heidenreich A, Walsemann G, Beyrouthy MJ, et al. Caspase-Dependent Regulation and Subcellular Redistribution of the Transcriptional Modulator YY1 during Apoptosis. Mol Cell Biol 2005;25:3704-14.
96. Usheva A, Shenk T. YY1 transcriptional initiator: protein interactions and association with a DNA site containing unpaired strands. Proc Natl Acad Sci USA 1996;93:13571-6.
97. Seto E, Lewis B, Shenk T. Interaction between transcription factors Sp1 and YY1. Nature 1993;365:462-4.
98. Austen M, Luscher B, Luscher-Firzlaff JM. Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. J Biol Chem 1997;272:1709-17.
99. Renna M, Caporaso MG, Bonatti S, Kaufman RJ, Remondelli P. Regulation of ergic-53 gene transcription in response to endoplasmic reticulum stress. J Biol Chem 2007;282:22499-512.
100. Flanagan JR. Autologous stimulation of YY1 transcription factor expression: role of an insulin-like growth factor. Cell Growth Differ 1995;6:185-90.
101. Santiago FS, Lowe HC, Bobryshev YV, Khachigian LM. Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury. Autocrine/paracrine role of endogenous fibroblast growth factor-2. J Biol Chem 2001;276:41143-9.
102. Li H, Liu H, Wang Z, et al. The role of transcription factors Sp1 and YY1 in proximal promoter region in initiation of transcription of the mu opioid receptor gene in human lymphocytes. J Cell Biochem 2008;104:237-50.
103. Hara Y, Kusumi Y, Mitsumata M, Li XK, Fujino M. Lysophosphatidylcholine upregulates LOX-1, chemokine receptors, and activation-related transcription factors in human T-cell line Jurkat. J Thromb Thrombolysis 2008;26:113-8.
104. Wang H, Hertlein E, Bakkar N, et al. NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol Cell Biol 2007;27:4374-87.
105. Huerta-Yepez S, Vega M, Garban H, Bonavida B. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Clin Immunol 2006;120:297-309.
106. Vega MI, Jazirehi AR, Huerta-Yepez S, Bonavida B. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappaB activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively. J Immunol 2005;175:2174-83.
107. Joshi B, Rastogi S, Morris M, et al. Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites. Biochem J 2007;401:155-66.
108. Baritaki S, Katsman A, Chatterjee D, Yeung KC, Spandidos DA, Bonavida B. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol 2007;179:5441-53.
109. Huerta-Yepez S, Vega M, Escoto-Chavez SE, et al. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1. Nitric Oxide 2009;20:39-52.
110. Hongo F, Garban H, Huerta-Yepez S, et al. Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation. Biochem Biophys Res Commun 2005;336:692-701.
111. Porichis F, Morou A, Baritaki S, Spandidos DA, Krambovitis E. Activation-induced cell death signalling in CD4+ T cells by staphylococcal enterotoxin A. Toxicol Lett 2008;176:77-84.
112. Joo M, Wright JG, Hu NN, et al. Yin Yang 1 enhances cyclooxygenase-2 gene expression in macrophages. Am J Physiol Lung Cell Mol Physiol 2007;292:L1219-26.
113. Xie J, Briggs JA, Briggs RC. Human hematopoietic cell specific nuclear protein MNDA interacts with the multifunctional transcription factor YY1 and stimulates YY1 DNA binding. J Cell Biochem 1998;70:489-506.
114. Seligson D, Horvath S, Huerta-Yepez S, et al. Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol 2005;27:131-41.
115. Erkeland SJ, Valkhof M, Heijmans-Antonissen C, et al. The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood 2003;101:1111-7.
116. de Nigris F, Botti C, de Chiara A, et al. Expression of transcription factor Yin Yang 1 in human osteosarcomas. Eur J Cancer 2006;42:2420-4.
117. de Nigris F, Botti C, Rossiello R, Crimi E, Sica V, Napoli C. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene 2007;26:382-94.
118. Baritaki S, Sifakis S, Huerta-Yepez S, et al. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int J Oncol 2007;31:69-79.
119. Baritaki S, Chatzinikola AM, Vakis AF, et al. YY1 over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels. Cancer Invest 2009;27:184-92.
120. Berchuck A, Iversen ES, Lancaster JM, et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res 2005;11:3686-96.
121. Sakhinia E, Glennie C, Hoyland JA, et al. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood 2007;109:3922-8.
122. Chinnappan D, Xiao D, Ratnasari A, Andry C, King TC, Weber HC. Transcription factor YY1 expression in human gastrointestinal cancer cells. Int J Oncol 2009;34:1417-23.
123. de Nigris F, Rossiello R, Schiano C, et al. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. Cancer Res 2008;68:1797-808.
124. Thomassen M, Tan Q, Kruse TA. Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer. BMC Cancer 2008;8:394.
125. Matsumura N, Huang Z, Baba T, et al. Yin yang 1 modulates taxane response in epithelial ovarian cancer. Mol Cancer Res 2009;7:210-20.
126. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 2003;22:5323-35.
127. Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 2008;647:21-9.
128. Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002;419:624-9.
129. Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle 2006;5:1886-901.
130. Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005;436:725-30.
131. Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V. Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene 2004;23:5759-69.
132. Yu J, Yu J, Rhodes DR, et al. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Res 2007;67:10657-63.
133. Bryant RJ, Cross NA, Eaton CL, Hamdy FC, Cunliffe VT. EZH2 promotes proliferation and invasiveness of prostate cancer cells. Prostate 2007;67:547-56.
134. Bryant RJ, Winder SJ, Cross SS, Hamdy FC, Cunliffe VT. The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells. Prostate 2008;68:255-63.
135. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
136. Arends JW. Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol 2000;190:412-6.
137. Bonavida B, Huerta-Yepez S, Goodglick L, Mizutani Y, Miki T. Can we develop biomarkers that predict response of cancer patients to immunotherapy? Biomarkers 2005;10 Suppl 1:69-76.
138. Vega MI, Huerta-Yepez S, Jazirehi AR, Garban H, Bonavida B. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis. Oncogene 2005;24:8114-27.
139. Hsu KW, Hsieh RH, Lee YH, et al. The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity. Mol Cell Biol 2008;28:4829-42.
140. Li WW, Hsiung Y, Zhou Y, Roy B, Lee AS. Induction of the mammalian GRP78/BiP gene by Ca2+ depletion and formation of aberrant proteins: activation of the conserved stress-inducible grp core promoter element by the human nuclear factor YY1. Mol Cell Biol 1997;17:54-60.
141. Mao C, Tai WC, Bai Y, Poizat C, Lee AS. In vivo regulation of Grp78/BiP transcription in the embryonic heart: role of the endoplasmic reticulum stress response element and GATA-4. J Biol Chem 2006;281:8877-87.
142. Takasaki N, Kurokawa D, Nakayama R, Nakayama J, Aizawa S. Acetylated YY1 regulates Otx2 expression in anterior neuroectoderm at two cis-sites 90 kb apart. EMBO J 2007;26:1649-59.
143. Di C, Liao S, Adamson DC, et al. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res 2005;65:919-24.
144. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005;132:3151-61.
145. Satoh K, Ginsburg E, Vonderhaar BK. Msx-1 and Msx-2 in mammary gland development. J Mammary Gland Biol Neoplasia 2004;9:195-205.
146. Hehlgans T, Strominger JL. Activation of transcription by binding of NF-E1 (YY1) to a newly identified element in the first exon of the human DR alpha gene. J Immunol 1995;154:5181-7.
147. Rangel LB, Agarwal R, Sherman-Baust CA, et al. Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers. Cancer Biol Ther 2004;3:1021-7.
148. Brule S, Sayasith K, Sirois J, Silversides DW, Lussier JG. Structure of the bovine VASAP-60/PRKCSH gene, functional analysis of the promoter, and gene expression analysis. Gene 2007;391:63-75.
149. Kim JD, Yu S, Choo JH, Kim J. Two evolutionarily conserved sequence elements for Peg3/Usp29 transcription. BMC Mol Biol 2008;9:108.
150. Abbondanza C, de Nigris F, De Rosa C, Rossiello R, Puca GA, Napoli C. Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma. Oncol Res 2008;17:33-41.
151. Bheda A, Creek KE, Pirisi L. Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes. Oncogene 2008;27:4315-23.
152. Athanikar JN, Badge RM, Moran JV. A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res 2004;32:3846-55.
153. Berndt JA, Kim JG, Tosic M, Kim C, Hudson LD. The transcriptional regulator Yin Yang 1 activates the myelin PLP gene. J Neurochem 2001;77:935-42.
154. Buescher JL, Martinez LB, Sato S, Okuyama S, Ikezu T. YY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infection. J Neuroimmune Pharmacol 2009;4:103-15.
155. Labrie C, Lee BH, Mathews MB. Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter. Nucleic Acids Res 1995;23:3732-41.
156. Jiang L, Yao M, Shi J, Shen P, Niu G, Fei J. Yin yang 1 directly regulates the transcription of RE-1 silencing transcription factor. J Neurosci Res 2008;86:1209-16.
157. Majumder S. REST in good times and bad: roles in tumor suppressor and oncogenic activities. Cell Cycle 2006;5:1929-35.
158. Jacobsen BM, Skalnik DG. YY1 binds five cis-elements and trans-activates the myeloid cell-restricted gp91(phox) promoter. J Biol Chem 1999;274:29984-93.
159. Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 2008;266:37-52.
160. Glenn DJ, Wang F, Chen S, Nishimoto M, Gardner DG. Endothelin-stimulated human B-type natriuretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2. Hypertension 2009;53:549-55.
161. Holloway K, Sade H, Romero IA, Male D. Action of transcription factors in the control of transferrin receptor expression in human brain endothelium. J Mol Biol 2007;365:1271-84.
162. Natesan S, Gilman MZ. DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev 1993;7:2497-509.
163. Klar M, Bode J. Enhanceosome formation over the beta interferon promoter underlies a remote-control mechanism mediated by YY1 and YY2. Mol Cell Biol 2005;25:10159-70.
164. Miao J, Wang Z, Provencher H, et al. HOXB13 promotes ovarian cancer progression. Proc Natl Acad Sci USA 2007;104:17093-8.
165. Liu Q, Merkler KA, Zhang X, McLean MP. Prostaglandin F2alpha suppresses rat steroidogenic acute regulatory protein expression via induction of Yin Yang 1 protein and recruitment of histone deacetylase 1 protein. Endocrinology 2007;148:5209-19.
166. Kim HJ, Kim JE, Ha M, et al. Steroidogenic acute regulatory protein expression in the normal human brain and intracranial tumors. Brain Res 2003;978:245-9.
167. Franchina M, Woo AJ, Dods J, et al. The CD30 gene promoter microsatellite binds transcription factor Yin Yang 1 (YY1) and shows genetic instability in anaplastic large cell lymphoma. J Pathol 2008;214:65-74.
168. Lee BC, Lee TH, Zagozdzon R, Avraham S, Usheva A, Avraham HK. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration. Cancer Res 2005;65:2840-5.
169. He CQ, Ding NZ, Fan W. YY1 repressing peroxisome proliferator-activated receptor delta promoter. Mol Cell Biochem 2008;308:247-52.
170. Crawford EL, Blomquist T, Mullins DN, et al. CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions. Carcinogenesis 2007;28:2552-9.
171. Tone Y, Kojima Y, Furuuchi K, et al. OX40 Gene Expression Is Up-Regulated by Chromatin Remodeling in Its Promoter Region Containing Sp1/Sp3, YY1, and NF-{kappa}B Binding Sites. J Immunol 2007;179:1760-7.
172. Redmond WL, Weinberg AD. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer. Crit Rev Immunol 2007;27:415-36.
173. Cicatiello L, Addeo R, Sasso A, et al. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol Cell Biol 2004;24:7260-74.
174. Alvarez-Salas LM, Benitez-Hess ML, Dipaolo JA. YY-1 and c-Jun transcription factors participate in the repression of the human involucrin promoter. Int J Oncol 2005;26:259-66.
175. Kobrossy L, Rastegar M, Featherstone M. Interplay between chromatin and trans-acting factors regulating the Hoxd4 promoter during neural differentiation. J Biol Chem 2006.
176. Yang WM, Yao YL, Sun JM, Davie JR, Seto E. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J Biol Chem 1997;272:28001-7.
177. Sucharov CC, Langer S, Bristow M, Leinwand L. Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A. Am J Physiol Cell Physiol 2006;291:C1029-37.
178. Kuzmichev A, Jenuwein T, Tempst P, Reinberg D. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 2004;14:183-93.
179. Filippova GN. Genetics and epigenetics of the multifunctional protein CTCF. Curr Top Dev Biol 2008;80:337-60.
180. Liao WR, Hsieh RH, Hsu KW, et al. The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1. Carcinogenesis 2007;28:1867-76.
181. Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 1993;262:1889-92.
182. Yeh TS, Lin YM, Hsieh RH, Tseng MJ. Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch. J Biol Chem 2003;278:41963-9.
183. Kuzmin A, Han Z, Golding MC, Mann MR, Latham KE, Varmuza S. The PcG gene Sfmbt2 is paternally expressed in extraembryonic tissues. Gene Expr Patterns 2008;8:107-16.
184. Ohtomo T, Horii T, Nomizu M, Suga T, Yamada J. Molecular cloning of a structural homolog of YY1AP, a coactivator of the multifunctional transcription factor YY1. Amino Acids 2007;33:645-52.
185. Wang CY, Liang YJ, Lin YS, Shih HM, Jou YS, Yu WC. YY1AP, a novel co-activator of YY1. J Biol Chem 2004;279:17750-5.
186. Li L, Shi Y, Wu H, et al. Hepatocellular carcinoma-associated gene 2 interacts with MAD2L2. Mol Cell Biochem 2007;304:297-304.
187. Kalenik JL, Chen D, Bradley ME, Chen SJ, Lee TC. Yeast two-hybrid cloning of a novel zinc finger protein that interacts with the multifunctional transcription factor YY1. Nucleic Acids Res 1997;25:843-9.
188. Bannasch D, Madge B, Schwab M. Functional interaction of Yaf2 with the central region of MycN. Oncogene 2001;20:5913-9.
189. Huang WH, Mai RT, Lee YH. Transcription factor YY1 and its associated acetyltransferases CBP and p300 interact with hepatitis delta antigens and modulate hepatitis delta virus RNA replication. J Virol 2008;82:7313-24.
190. Kang HC, Chung BM, Chae JH, Yang SI, Kim CG, Kim CG. Identification and characterization of four novel peptide motifs that recognize distinct regions of the transcription factor CP2. FEBS J 2005;272:1265-77.
191. Lee KH, Evans S, Ruan TY, Lassar AB. SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer. Development 2004;131:4709-23.
192. Ralph WM, Jr., Liu K, Auborn KJ. CCAAT/enhancer-binding protein beta represses human papillomavirus 11 upstream regulatory region expression through a promoter-proximal YY1-binding site. J Gen Virol 2006;87(Pt 1):51-9.